Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
Arcturus Therapeutics (ARCT) Stock Price & Analysis
1,092 Followers
ARCT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.70 - $33.80
Previous Close$28.48
Volume347.83K
Average Volume (3M)522.79K
Market Cap
$756.51M
Enterprise Value$457.76M
Total Cash (Recent Filing)$327.94M
Total Debt (Recent Filing)$29.19M
Price to Earnings (P/E)6.8
Beta2.03
Next Earnings
Aug 08, 2023EPS Estimate
-$0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.19
Shares Outstanding26,562,951
10 Day Avg. Volume293,355
30 Day Avg. Volume522,794
Standard Deviation0.32
R-Squared0.19
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)2.64
Price to Sales (P/S)8.85
Price to Cash Flow (P/CF)1.10
P/FCF Ratio1.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.63
Enterprise Value/Gross Profit2.22
Enterprise Value/Ebitda4.02
Forecast
1Y Price Target
$51.40Price Target Upside80.48% Upside
Rating ConsensusHold
Number of Analyst Covering5
Arcturus Therapeutics News
Market NewsArcturus Surges after Q4 Earnings Beat
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ARCT FAQ
What was Arcturus Therapeutics’s price range in the past 12 months?
Arcturus Therapeutics lowest stock price was $11.70 and its highest was $33.80 in the past 12 months.
What is Arcturus Therapeutics’s market cap?
Currently, no data Available
When is Arcturus Therapeutics’s upcoming earnings report date?
Arcturus Therapeutics’s upcoming earnings report date is Aug 08, 2023 which is in 61 days.
How were Arcturus Therapeutics’s earnings last quarter?
Arcturus Therapeutics released its earnings results on May 09, 2023. The company reported $1.87 earnings per share for the quarter, beating the consensus estimate of $0.06 by $1.81.
Is Arcturus Therapeutics overvalued?
According to Wall Street analysts Arcturus Therapeutics’s price is currently Undervalued.
Does Arcturus Therapeutics pay dividends?
Arcturus Therapeutics does not currently pay dividends.
What is Arcturus Therapeutics’s EPS estimate?
Arcturus Therapeutics’s EPS estimate is -$0.5.
How many shares outstanding does Arcturus Therapeutics have?
Arcturus Therapeutics has 26,562,950 shares outstanding.
What happened to Arcturus Therapeutics’s price movement after its last earnings report?
Arcturus Therapeutics reported an EPS of $1.87 in its last earnings report, beating expectations of $0.06. Following the earnings report the stock price went up 1.589%.
Which hedge fund is a major shareholder of Arcturus Therapeutics?
Among the largest hedge funds holding Arcturus Therapeutics’s share is ARK Investment Management LLC. It holds Arcturus Therapeutics’s shares valued at 48M.
---
Arcturus Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$51.40 (80.48% Upside)
$51.40 (80.48% Upside)
Blogger Sentiment
Bullish
ARCT Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 39.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.1%
Last 30 Days ▲ 19.9%
Last 30 Days ▲ 19.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
45.75%
12-Months-Change
Fundamentals
Return on Equity
43.30%
Trailing 12-Months
Asset Growth
37.68%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Arcturus Therapeutics
Arcturus Therapeutics Holdings, Inc. engages in the development of RNA therapeutics for treatment. It focuses on liver and respiratory diseases. Its pipeline include LUNAR-OTC, and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA.
---
Top 5 ETFs holding ARCT
iShares Biotechnology ETF
$4.72M
Vanguard Health Care ETF
$2.19M
Fidelity Nasdaq Composite Index ETF
$390.14K
Fidelity MSCI Health Care Index ETF
$342.00K
iShares NASDAQ US Biotechnology UCITS ETF
$326.32K
Up to five ETFs with an Outperform Smart Score that hold ARCT. The ETFs are listed according to market value of ARCT within the ETF
---
---